Gonzalez-Gonzalez A.; Vazquez C.; Encalada R.; Saavedra E.; Vazquez-Jimenez L.K.; Ortiz-Perez E.; Bolognesi M.L.; Rivera G., Phenothiazine-based virtual screening, molecular docking, and molecular dynamics of new trypanothione reductase inhibitors of Trypanosoma cruzi, «MOLECULAR INFORMATICS», 2023, 42, Article number: 2300069, pp. 2300069 - 2300069 [articolo]
Guardigni M.; Pruccoli L.; Santini A.; Simone A.D.; Bersani M.; Spyrakis F.; Frabetti F.; Uliassi E.; Andrisano V.; Pagliarani B.; Fernández-Gómez P.; Palomo V.; Bolognesi M.L.; Tarozzi A.; Milelli A., PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer’s Disease, «ACS CHEMICAL NEUROSCIENCE», 2023, 14, pp. 1963 - 1970 [articolo]Open Access
Uliassi, E; Bergamini, C; Rizzardi, N; Naldi, M; Cores, A; Bartolini, M; Menéndez, JC; Bolognesi, ML, Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease, «BIOORGANIC & MEDICINAL CHEMISTRY», 2023, 91, Article number: 117419, pp. 1 - 9 [articolo]Open Access
Rocío Marisol Espinoza Chávez; Salerno A.; Liuzzi A.; Ilari A.; Milelli A.; Uliassi E.; Bolognesi M.L., Targeted Protein Degradation for Infectious Diseases: from Basic Biology to Drug Discovery, «ACS BIO & MED CHEM AU», 2023, 3, pp. 32 - 45 [articolo]Open Access
Bagnolini, G.; Falchi, F.; Sdei, F.; Roberti, M.; Sosic, A.; Sissi, C.; Bolognesi, M. L., Triggering RNA degradation with small molecules: development of RIBOnuclease TArgeting Chimeras (RIBOTACs), in: Book of abstract, 2023(atti di: XXVIII National Meeting on Medicinal Chemistry (NMMC28), Chieti, 17-20 September 2023) [atti di convegno-poster]
Nunes Lemes L.F.; Magoulas G.E.; Souza de Oliveira A.; Barrias E.; de Camargo Nascente L.; Granado R.; Teixeira de Macedo Silva S.; Assimomytis N.; de Souza W.; Bolognesi M.L.; Romeiro L.A.S.; Calogeropoulou T., Valorizing Constituents of Cashew Nut Shell Liquid toward the Sustainable Development of New Drugs against Chagas Disease, «ACS INFECTIOUS DISEASES», 2023, 9, pp. 1334 - 1345 [articolo]
Gandini, Annachiara; Gonçalves, Ana Elisa; Strocchi, Silvia; Albertini, Claudia; Janočková, Jana; Tramarin, Anna; Grifoni, Daniela; Poeta, Eleonora; Soukup, Ondrej; Muñoz-Torrero, Diego; Monti, Barbara; Sabaté, Raimon; Bartolini, Manuela; Legname, Giuseppe; Bolognesi, Maria Laura, Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer's Disease, «ACS CHEMICAL NEUROSCIENCE», 2022, 13, pp. 3314 - 3329 [articolo]Open Access
Salerno, Alessandra; Seghetti, Francesca; Caciolla, Jessica; Uliassi, Elisa; Testi, Eleonora; Guardigni, Melissa; Roberti, Marinella; Milelli, Andrea; Bolognesi, Maria Laura, Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One, «JOURNAL OF MEDICINAL CHEMISTRY», 2022, 65, pp. 9507 - 9530 [articolo]Open Access
Lauriola A.; Uliassi E.; Santucci M.; Bolognesi M.L.; Mor M.; Scalvini L.; Elisi G.M.; Gozzi G.; Tagliazucchi L.; Marverti G.; Ferrari S.; Losi L.; D'Arca D.; Costi M.P., Identification of a Quinone Derivative as a YAP/TEAD Activity Modulator from a Repurposing Library, «PHARMACEUTICS», 2022, 14, Article number: 391, pp. 1 - 22 [articolo]Open Access
González-González, Alonzo; Sánchez-Sánchez, Oscar; Krauth-Siegel, R Luise; Bolognesi, Maria Laura; Gớmez-Escobedo, Rogelio; Nogueda-Torres, Benjamín; Vázquez-Jiménez, Lenci K; Saavedra, Emma; Encalada, Rusely; Espinoza-Hicks, José Carlos; Paz-González, Alma D; Rivera, Gildardo, In Vitro and In Silico Analysis of New n-Butyl and Isobutyl Quinoxaline-7-carboxylate 1,4-di-N-oxide Derivatives against Trypanosoma cruzi as Trypanothione Reductase Inhibitors, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2022, 23, pp. 13315 - 13332 [articolo]Open Access
Colini Baldeschi, Arianna; Zattoni, Marco; Vanni, Silvia; Nikolic, Lea; Ferracin, Chiara; La Sala, Giuseppina; Summa, Maria; Bertorelli, Rosalia; Bertozzi, Sine Mandrup; Giachin, Gabriele; Carloni, Paolo; Bolognesi, Maria Laura; De Vivo, Marco; Legname, Giuseppe, Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion Clearance, «JOURNAL OF MEDICINAL CHEMISTRY», 2022, 65, pp. 8998 - 9010 [articolo]Open Access
Santini, A.; Pruccoli, L.; Guardigni, M.; De Simone, A.; Spyrakis, F.; Frabetti, F.; Andrisano, V.; Bolognesi, M. L.; Tarozzi, A.; Milelli, A., PROTAC-INDUCED GLYCOGEN SYNTHASE KINASE 3B DEGRADATION, in: XXVII National Meeting on Medicinal Chemistry, 2022, pp. 160 - 160 (atti di: XXVII National Meeting on Medicinal Chemistry, Bari, 11-14 settembre 2022) [atti di convegno-poster]
Albertini, C; Salerno, A; Atzenti, S; Uliassi, E; Massenzio, F; Maruca, A; Rocca, R; Mecava, M; Silva, FSG; Mena, D; Valente, P; Duarte, AI; Chavarria, D; Bissaro, M; Moro, S; Federico, S; Spalluto, G; Soukup, O; Borges, F; Alcaro, S; Monti, B; Oliveira, PJ; Menendez, JC; Bolognesi, ML, Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis, «ACS CHEMICAL NEUROSCIENCE», 2022, 13, pp. 2252 - 2260 [articolo]Open Access
Bianco M.D.C.A.D.; Inacio Leite D.; Silva Castelo Branco F.; Boechat N.; Uliassi E.; Bolognesi M.L.; Bastos M.M., The Use of Zidovudine Pharmacophore in Multi-Target-Directed Ligands for AIDS Therapy, «MOLECULES», 2022, 27, Article number: 8502, pp. 8502 - 8523 [articolo]Open Access
Uliassi, Elisa; Nikolic, Lea; Bolognesi, Maria Laura; Legname, Giuseppe, Therapeutic strategies for identifying small molecules against prion diseases, «CELL & TISSUE RESEARCH», 2022, x, pp. 1 - 11 [articolo]
